D75.81 - Myelofibrosis

  • Applicable to Myelofibrosis
  • The 2025 edition of ICD10-CM D75.81 became effective on October 1, 2024.
  • This is the American ICD10-CM version of D75.81 - other international versions of ICD10 D75.81 may differ.
  • D75.81 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

Code Additional Code

  • code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)

 Inclusion Term

  • Myelofibrosis NOS
  • Secondary myelofibrosis NOS

Type 1 Excludes

  • acute myelofibrosis (C94.4-)
  • idiopathic myelofibrosis (D47.1)
  • leukoerythroblastic anemia (D61.82)
  • myelofibrosis with myeloid metaplasia (D47.4)
  • myelophthisic anemia (D61.82)
  • myelophthisis (D61.82)
  • primary myelofibrosis (D47.1)

codefirst

  • the underlying disorder, such as:
  • malignant neoplasm of breast (C50.-)

The following codes above D75.81 contain annotation back-references that may be applicable to D75.81:

Chapter: D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Section: D70-D77 Other disorders of blood and blood-forming organs

Category: D75 Other and unspecified diseases of blood and blood-forming organs

      
Billable/Specific Code

Browse other similar CM codes

                

Please, give attribution to our website icd-10code.com